切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2015, Vol. 09 ›› Issue (01) : 1 -4. doi: 10.3877/cma. j. issn.1674-0807.2015.01.001

专家论坛

癌症全身治疗难点问题的思考及展望
陆正鑫1,(), 姜军2,()   
  1. 1.226200 江苏启东,盖天力药业有限公司,单位地址: 江苏省启东市和平南路88 号
    2.400038 重庆,第三军医大学西南医院乳腺外科
  • 收稿日期:2015-01-25 出版日期:2015-02-01
  • 通信作者: 陆正鑫, 姜军

Reflection and prospect in systemic treatment of cancer

Zhengxin Lu(), Jun Jiang()   

  • Received:2015-01-25 Published:2015-02-01
  • Corresponding author: Zhengxin Lu, Jun Jiang
引用本文:

陆正鑫, 姜军. 癌症全身治疗难点问题的思考及展望[J/OL]. 中华乳腺病杂志(电子版), 2015, 09(01): 1-4.

Zhengxin Lu, Jun Jiang. Reflection and prospect in systemic treatment of cancer[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2015, 09(01): 1-4.

[1]
Jemal A,Bray F,Center MM,et al.Global cancer statistics[J].CA Cancer J Clin,2011,61(2): 69-90.
[2]
赵平,陈万青.2010 中国肿瘤登记年报[M]. 北京: 军事医学科学出版社,2011: 2.
[3]
Chen W,Zheng R,Zhang S,et al. Report of incidence and mortality in China cancer registries, 2009[J]. Chin J Cancer Res,2013,25(1): 10-21.
[4]
Stingl J,Caldas C.Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis[J]. Nat Rev Cancer,2007,7(10): 791-799.
[5]
Lujambio A,Lowe SW.The microcosmos of cancer[J].Nature,2012,482(7385): 347-355.
[6]
McAllister SS, Weinberg RA. The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis[J]. Nat Cell Biol,2014,16(8): 717-727.
[7]
Perrino C,Schiattarella GG,Magliulo F,et al. Cardiac side effects of chemotherapy: state of art and strategies for a correct management[J]. Curr Vasc Pharmacol,2014,12(1): 106-116.
[8]
MacDonald V. Chemotherapy: managing side effects and safe handling[J]. Can Vet J,2009,50(6): 665-668.
[9]
Valent P,Bonnet D,De Maria R,et al. Cancer stem cell definitions and terminology: the devil is in the details[J]. Nat Rev Cancer,2012,12(11): 767-775.
[10]
Visvader JE.Cells of origin in cancer[J]. Nature,2011,469(7330): 314-322.
[11]
Meacham CE,Morrison SJ. Tumour heterogeneity and cancer cell plasticity[J].Nature,2013,501(7467): 328-337.
[12]
Massagué J.G1 cell-cycle control and cancer[J].Nature,2004,432(7015): 298-306.
[13]
Reya T, Morrison SJ, Clarke MF,et al. Stem cells, cancer,and cancer stem cells[J].Nature,2001,414(6859): 105-111.
[14]
Coussens LM,Werb Z. Inflammation and cancer[J]. Nature,2002,420(6917): 860-867.
[15]
Medema JP,Vermeulen L. Microenvironmental regulation of stem cells in intestinal homeostasis and cancer[J]. Nature,2011,474(7351): 318-326.
[16]
Jenq RR, van den Brink MR. Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer[J].Nat Rev Cancer,2010,10(3): 213-221.
[17]
Anderson MR,Green HN. Implications of the immunological theory of cancer to multiple causes[J]. Nature,1965,208(5008): 338-339.
[18]
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation[J].Cell,2011,144(5): 646-674.
[19]
Vineis P, Wild CP. Global cancer patterns: causes and prevention[J].Lancet,2014,383(9916): 549-557.
[20]
Finkel T,Serrano M,Blasco MA.The common biology of cancer and ageing[J].Nature,2007,448(7155): 767-774.
[21]
Ribatti D.Cancer stem cells and tumor angiogenesis[J].Cancer Lett,2012,321(1): 13-17.
[22]
Zhao Y, Bao Q, Renner A, et al. Cancer stem cells and angiogenesis[J].Int J Dev Biol,2011,55(4/5): 477-482.
[23]
Li PW.Application of traditional Chinese patent drugs in cancer treatment[J].Zhonghua Zhong Liu Za Zhi,2011,33(5): 400.
[24]
Baumann S,Fas SC,Giaisi M,et al.Wogonin preferentially kills malignant lymphocytes and suppresses T-cell tumor growth by inducing PLC gamma 1- and Ca2+-dependent apoptosis[J].Blood,2008,111(4): 2354-2363.
[25]
Bergh J, Mariani G, Cardoso F, et al. Clinical and pharmacokinetic study of sunitinib and docetaxel in women with advanced breast cancer[J].Breast,2012,21(4): 507-513.
[26]
Zhang N, Kong X,Yan S,et al.Huaier aqueous extract inhibits proliferation of breast cancer cells by inducing apoptosis[J].Cancer Sci,2010,101(11): 2375-2383.
[27]
Ferrara N,Kerbel RS.Angiogenesis as a therapeutic target[J].Nature,2005,438(7070): 967-974.
[28]
胡保全,唐鹏,齐晓伟,等. 槐耳清膏对乳腺癌细胞系SUM-159 细胞干性特征的影响[J]. 第三军医大学学报,2013,35(11): 1107-1110.
[29]
Topalian SL,Weiner GJ,Pardoll DM. Cancer immunotherapy comes of age[J].J Clin Oncol,2011,29(36): 4828-4836.
[30]
Dewan MZ,Terunuma H, Takada M,et al.Role of natural killer cells in hormone-independent rapid tumor formation and spontaneous metastasis of breast cancer cells in vivo[J].Breast Cancer Res Treat,2007,104(3): 267-275.
[31]
汤钊猷. 癌转移研究的几个重要问题[J].中华消化外科杂志,2014,13(3): 161-164.
[1] 李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[2] 陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[3] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[4] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[5] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[6] 任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[7] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[8] 吴晖, 佴永军, 施雪松, 魏晓为. 两种解剖入路下行直肠癌侧方淋巴结清扫的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 40-43.
[9] 周世振, 朱兴亚, 袁庆港, 刘理想, 王凯, 缪骥, 丁超, 汪灏, 管文贤. 吲哚菁绿荧光成像技术在腹腔镜直肠癌侧方淋巴结清扫中的应用效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 44-47.
[10] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[11] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[12] 张洁, 罗小霞, 余鸿. 系统性免疫炎症指数对急性胰腺炎患者并发器官功能损伤的预测价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 68-71.
[13] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[14] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[15] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
阅读次数
全文


摘要